Articles From: Cubist Names Dr. Patrick Vink Chief Operating Officer to Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results


Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Patrick Vink, M.D., M.B.A., currently Senior Vice President and General Manager of Cubist’s International Business, has been promoted to Executive Vice President and Chief Operating Officer, effective January 1, 2015.
Sign-up for Cubist Names Dr. Patrick Vink Chief Operating Officer investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) breached their fiduciary duties in connection with the planned merger of the Company with Merck & Co., Inc. Cubist is engaged in the research, development, and commercialization of pharmaceutical products for medical needs in the acute care environment.
Sign-up for CUBIST PHARMACEUTICALS ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Cubist Pharmaceuticals, Inc. to Merck investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cubist Pharmaceuticals NEW YORK , Dec.
Sign-up for CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its Board of Directors has selected Robert J.
Sign-up for Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer investment picks
2014/12/8
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cubist Pharmaceuticals, Inc. (“Cubist”) (NASDAQ GS:CBST) concerning the sale to Merck & Co., Inc. Under the terms of the agreement, Cubist shareholders will receive $102.00 in cash for each share owned, which is only a 37% premium over the share price just before the deal was announced and only a slight premium over the 52-week high.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc. investment picks
2014/12/11
Rigrodsky & Long, P.A.: Do you own shares of Cubist Pharmaceuticals, Inc. (NASDAQ GS: CBST )? Did you purchase any of your shares prior to December 8, 2014?
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/12/8
WILMINGTON, Del.
Sign-up for CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the third quarter ended September 30, 2014.
Sign-up for Cubist Reports Third Quarter 2014 Financial Results investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its third quarter 2014 financial results at 4:00 p.m. ET on Tuesday, October 21, 2014.
Sign-up for Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014 investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Michael Tomsicek, Cubist’s SVP & Chief Financial Officer, will present at the Jefferies 2014 Healthcare Conference on Wednesday, November 19, to discuss the company’s business activities, financial outlook, and current news.
Sign-up for Cubist to Present at Jefferies 2014 Healthcare Conference investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it will present new data from a phase 1 safety and pharmacokinetic study of fidaxomicin in children with Clostridium difficile- associated diarrhea (CDAD) at IDWeek 2014, being held October 8-12 in Philadelphia.
Sign-up for Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014 investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data from its antibiotics portfolio at IDWeek 2014, October 8-12, in Philadelphia, PA.
Sign-up for Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014 investment picks
2014/12/8
CUC Announces 39.7 MW Generation Expansion Project With BWSC & MAN Diesel & Turbo Canada NewsWire CARIBBEAN UTILITIES COMPANY, LTD.
Sign-up for CUC Announces 39.7 MW Generation Expansion Project With BWSC & MAN Diesel & Turbo investment picks
2014/11/12
CUC Announces Declaration of Dividend an Class A Ordinary Shares Canada NewsWire CARIBBEAN UTILITIES COMPANY, LTD.
Sign-up for CUC Announces Declaration of Dividend an Class A Ordinary Shares investment picks
TUALATIN, Ore.
Sign-up for CUI Global Reports Unaudited Third Quarter 2014 Financial Results investment picks
TUALATIN, Ore.
Sign-up for CUI Global, Inc. To Ring The NASDAQ Stock Market Closing Bell investment picks
Architects of Modern Power (AMP) promises to advance power system technology and boost supply chain reliability for distributed power systems TUALATIN, Ore.
Sign-up for CUI Global, Inc.'s Wholly-Owned Subsidiary, CUI Inc, Named as One of Three Founding Members of Digital Power Consortium, "Architects of Modern Power" investment picks
2014/10/30
SAN ANTONIO , Oct.
Sign-up for Cullen/Frost Bankers Declares Quarterly Cash Dividend For Common Stock And Preferred Stock investment picks
SAN ANTONIO , Oct.
Sign-up for Cullen/Frost Bankers, Inc. Hosts Third Quarter 2014 Earnings Conference Call investment picks
- Average loans increase 14.7 percent - Average deposits rise 16.9 percent - Asset quality continues to improve SAN ANTONIO , Oct.
Sign-up for Cullen/Frost Reports Strong Third Quarter Results investment picks
Culp, Inc. (NYSE: CFI) today reported financial and operating results for the second quarter and six months ended November 2, 2014.
Sign-up for Culp Announces Results for Second Quarter Fiscal 2015 investment picks
Culp, Inc. (NYSE: CFI), today announced that it will provide an online, real-time webcast and rebroadcast of its fiscal 2015 second quarter conference call on Thursday, December 4, 2014, at 11:00 a.m. ET.
Sign-up for Culp, Inc. to Broadcast Fiscal 2015 Second Quarter Conference Call Live on the Internet investment picks
http://media.marketwire.com/attachments/201211/98749_netapp.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153636&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Culture of Trust Earns NetApp #3 Best Place to Work in the World investment picks
- Revenues up nearly 50% from prior year period NASHVILLE, Tenn.
Sign-up for Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cubist Names Dr. Patrick Vink Chief Operating Officer to Cumberland Pharmaceuticals Reports Third Quarter 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent